Patent · US Active

Compositions comprising PCSK9-binding molecules and methods of use

US12410236B2 · kind B2 · utility

0Cited by
7References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 16, 2023
Grant dateSep 9, 2025
Priority date—
Expiry dateMay 16, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/74
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides pharmaceutical compositions comprising fibronectin based scaffold domain proteins that bind, for example, proprotein convertase subtilisin kexin-9 (PCSK9).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.